NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,072 filers reported holding NOVARTIS A G in Q3 2021. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $345,102 | -4.6% | 3,388 | -5.5% | 0.09% | -3.1% |
| Q2 2023 | $361,863 | +21.1% | 3,586 | +10.4% | 0.10% | +10.3% |
| Q1 2023 | $298,908 | -37.2% | 3,249 | -38.0% | 0.09% | -40.4% |
| Q4 2022 | $475,736 | +3.4% | 5,244 | -13.4% | 0.15% | -7.0% |
| Q3 2022 | $460,000 | -11.0% | 6,054 | -1.1% | 0.16% | -8.7% |
| Q2 2022 | $517,000 | -2.8% | 6,124 | +0.8% | 0.17% | +16.2% |
| Q1 2022 | $532,000 | +97.0% | 6,074 | +96.5% | 0.15% | +111.4% |
| Q4 2021 | $270,000 | -49.7% | 3,091 | -53.0% | 0.07% | -52.4% |
| Q3 2021 | $537,000 | -9.0% | 6,578 | +1.7% | 0.15% | -12.0% |
| Q2 2021 | $590,000 | +9.5% | 6,469 | +2.4% | 0.17% | +0.6% |
| Q1 2021 | $539,000 | -13.8% | 6,315 | -4.7% | 0.17% | -16.6% |
| Q4 2020 | $625,000 | +105.6% | 6,628 | +89.5% | 0.20% | +77.7% |
| Q3 2020 | $304,000 | +1.3% | 3,498 | +1.8% | 0.11% | -9.7% |
| Q2 2020 | $300,000 | +7.1% | 3,437 | +1.1% | 0.12% | -13.9% |
| Q1 2020 | $280,000 | +16.2% | 3,398 | +33.3% | 0.14% | +56.5% |
| Q4 2019 | $241,000 | – | 2,549 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PRENTISS SMITH & CO INC | 127,510 | $11,721,000 | 6.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 127,716 | $11,740,000 | 6.04% |
| EXENCIAL WEALTH ADVISORS, LLC | 116,917 | $10,747,000 | 5.25% |
| MCDANIEL TERRY & CO | 181,095 | $16,646,000 | 4.64% |
| Fayerweather Charles | 18,180 | $1,671,000 | 4.54% |
| Osher Van de Voorde Investment Management | 78,138 | $7,182,000 | 4.38% |
| BROWN BROTHERS HARRIMAN & CO | 9,291,495 | $854,074,000 | 4.35% |
| Boulegeris Investments, Inc. | 61,322 | $5,637,000 | 4.31% |
| DODGE & COX | 45,723,035 | $4,202,861,000 | 4.23% |
| WHV Investments, Inc. | 1,603,476 | $152,945,000 | 4.23% |